Table 1 Sex ratio, age, and clinical characteristics of the participants
From: Anger tendency may be associated with duration of illness in panic disorder
Total | Long PD duration | Short PD duration | |
|---|---|---|---|
N (Male/Female) | 413 (132/281) | 186 (58/128) | 200 (66/134) |
Age (mean (SD)) | 38.7 (10.5) | 42.4 (10.0) | 34.7 (9.7) |
PD duration (mean (SD)) | 10.4 (8.4) | 17.5 (7.4) | 4.0 (2.5) |
Fluvoxamine (mean (SD/range)) [mg] | 23.1 (36.1/0-300) | 23.7 (39.8/0-300) | 23.1 (33.9/0-150) |
(N (%) of users) | 172 (42.2%) | 75 (41.0%) | 85 (42.9%) |
Paroxetine (mean (SD/range)) [mg] | 7.8 (11.6/0-40) | 7.1 (11.5/0-40) | 8.6 (11.8/0-40) |
(N (%) of users) | 155 (38.0%) | 63 (34.4%) | 83 (41.9%) |
Milnacipran (mean (SD/range)) [mg] | 2.2 (11.3/0-100) | 3.1 (13.4/0-100) | 1.4 (9.1/0-100) |
(N (%) of users) | 19 (4.7%) | 12 (6.6%) | 6 (3.0%) |
Benzodiazepine (N (%) of users) | 386 (94.6%) | 178 (97.3%) | 183 (92.4%) |
Imipramine-equivalents (mean (SD)) | 73.1 (60.0) | 75.6 (65.5) | 71.7 (56.0) |
Agoraphobia (N (%)) | 238 (57.6%) | 112 (60.2%) | 108 (54.0%) |
SAD (N (%)) | 24 (5.8%) | 13 (7.0%) | 9 (4.5%) |
OCD (N (%)) | 19 (4.6%) | 7 (3.8%) | 10 (5.0%) |
GAD (N (%)) | 19 (4.6%) | 8 (4.3%) | 11 (5.5%) |
PTSD (N (%)) | 9 (2.2%) | 4 (2.2%) | 5 (2.5%) |
Major depressive episode (N (%)) | 51 (12.3%) | 27 (14.5%) | 20 (10.0%) |
Manic episode (N (%)) | 12 (2.9%) | 5 (2.7%) | 6 (3.0%) |
Hypomanic episode (N (%)) | 24 (5.8%) | 9 (4.8%) | 14 (7.0%) |